Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations.
暂无分享,去创建一个
[1] R Fisher,et al. Design of Experiments , 1936 .
[2] Robert D. Johnson,et al. Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.
[3] Naveen Ahuja,et al. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology , 2006, AAPS PharmSciTech.
[4] Marcel de Matas,et al. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[5] P. Wehrlé,et al. Statistical Tools for Process Control and Quality Improvement in the Pharmaceutical Industry , 1994 .
[6] H. Goicoechea,et al. Determination of loratadine and pseudoephedrine sulfate in pharmaceuticals based on non-linear second-order spectrophotometric data generated by a pH-gradient flow injection technique and artificial neural networks , 2007, Analytical and bioanalytical chemistry.
[7] William G. Cochran,et al. Experimental Designs, 2nd Edition , 1950 .
[8] Archit Yajnik,et al. Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parmaeters of cytarabine liposomes , 2004, AAPS PharmSciTech.
[9] Rajiv Kumar,et al. Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. , 2005, Critical reviews in therapeutic drug carrier systems.
[10] J. Swarbrick,et al. Encyclopedia of Pharmaceutical Technology , 2006 .
[11] Peter York,et al. Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] J. Parojčić,et al. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.
[13] William G. Cochran,et al. Experimental designs, 2nd ed. , 1957 .
[14] Alejandro C. Olivieri,et al. Complementary use of partial least-squares and artificial neural networks for the non-linear spectrophotometric analysis of pharmaceutical samples , 2002, Analytical and bioanalytical chemistry.
[15] Kozo Takayama,et al. Formulation Optimization of Paclitaxel Carried by PEGylated Emulsions Based on Artificial Neural Network , 2004, Pharmaceutical Research.
[16] Bhupinder Singh,et al. Optimizing drug delivery systems using systematic "design of experiments." Part II: retrospect and prospects. , 2005, Critical reviews in therapeutic drug carrier systems.
[17] N. Subramanian,et al. Comparison of artificial neural network and multiple linear regression in the optimization of formulation parameters of leuprolide acetate loaded liposomes. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[18] Peter York,et al. Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[19] Q Shao,et al. Comparison of neurofuzzy logic and decision trees in discovering knowledge from experimental data of an immediate release tablet formulation. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] Kozo Takayama,et al. Artificial Neural Network as a Novel Method to Optimize Pharmaceutical Formulations , 2004, Pharmaceutical Research.
[21] Marcel de Matas,et al. Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks. , 2007, Journal of pharmaceutical sciences.
[22] Christopher T. Rhodes,et al. Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .